Gong C - Search Results

1

Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer.

Hu C, Gu F, Tai Z, Yao C, Gong C, Xia Q, Gao Y, Gao S. Hu C, et al. Among authors: gong c. Oncotarget. 2016 Sep 20;7(38):61832-61844. doi: 10.18632/oncotarget.11451. Oncotarget. 2016. PMID: 27557520 Free PMC article.

2

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.

Gu F, Hu C, Tai Z, Yao C, Tian J, Zhang L, Xia Q, Gong C, Gao Y, Gao S. Gu F, et al. Among authors: gong c. Sci Rep. 2016 Nov 2;6:36281. doi: 10.1038/srep36281. Sci Rep. 2016. PMID: 27805051 Free PMC article.

3

Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment.

Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, Qiang L, Gao S, Gao Y. Gong C, et al. J Control Release. 2017 Nov 28;266:272-286. doi: 10.1016/j.jconrel.2017.09.042. Epub 2017 Oct 5. J Control Release. 2017. PMID: 28987884

4

A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.

Li Y, Gao Y, Gong C, Wang Z, Xia Q, Gu F, Hu C, Zhang L, Guo H, Gao S. Li Y, et al. Among authors: gong c. Nanomedicine. 2018 Oct;14(7):1973-1985. doi: 10.1016/j.nano.2018.05.020. Epub 2018 Jun 20. Nanomedicine. 2018. PMID: 29935333

5

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer.

Xia Q, Gong C, Gu F, Wang Z, Hu C, Zhang L, Qiang L, Ding X, Gao S, Gao Y. Xia Q, et al. Among authors: gong c. J Biomed Nanotechnol. 2018 Sep 1;14(9):1613-1626. doi: 10.1166/jbn.2018.2605. J Biomed Nanotechnol. 2018. PMID: 29958555

6

Codelivery of miR-4638-5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer.

Jiang W, Gao Y, Wang Z, Gong C, Hu C, Ding X, Qiang L, Gao S, Ren F. Jiang W, et al. Among authors: gong c. Mol Pharm. 2019 Jan 7;16(1):437-447. doi: 10.1021/acs.molpharmaceut.8b01074. Epub 2018 Dec 4. Mol Pharm. 2019. PMID: 30452268

7

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer.

Gu F, Hu C, Xia Q, Gong C, Gao S, Chen Z. Gu F, et al. Among authors: gong c. J Nanopart Res. 2018;20(11):303. doi: 10.1007/s11051-018-4407-z. Epub 2018 Nov 12. J Nanopart Res. 2018. PMID: 30524190 Free PMC article.

8

A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy.

Qiang L, Cai Z, Jiang W, Liu J, Tai Z, Li G, Gong C, Gao S, Gao Y. Qiang L, et al. Among authors: gong c. J Nanobiotechnology. 2019 Jul 10;17(1):83. doi: 10.1186/s12951-019-0513-z. J Nanobiotechnology. 2019. PMID: 31291948 Free PMC article.

9

Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.

Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, Qiang L, Li G, Han Z, Yuan Y, Gao S. Gong C, et al. J Nanobiotechnology. 2019 Sep 3;17(1):93. doi: 10.1186/s12951-019-0526-7. J Nanobiotechnology. 2019. PMID: 31481080 Free PMC article.

10

Dual-Blockade Immune Checkpoint for Breast Cancer Treatment Based on a Tumor-Penetrating Peptide Assembling Nanoparticle.

Li G, Gao Y, Gong C, Han Z, Qiang L, Tai Z, Tian J, Gao S. Li G, et al. Among authors: gong c. ACS Appl Mater Interfaces. 2019 Oct 30;11(43):39513-39524. doi: 10.1021/acsami.9b13354. Epub 2019 Oct 18. ACS Appl Mater Interfaces. 2019. PMID: 31599562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,474 results

Search Page

Filters